| Mesoporous silica nanoparticles for drug and gene delivery |
90 |
| An updated overview on the development of new photosensitizers for anticancer photodynamic therapy |
87 |
| Recent progress in drug delivery |
80 |
| Adapting liposomes for oral drug delivery |
60 |
| Human carboxylesterases: a comprehensive review |
56 |
| Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy |
54 |
| Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment |
48 |
| Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment |
35 |
| Recent developments in topoisomerase-targeted cancer chemotherapy |
34 |
| Biomacromolecules as carriers in drug delivery and tissue engineering |
33 |
| Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers |
33 |
| Drug metabolism in drug discovery and development |
32 |
| Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application |
31 |
| Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPK alpha/UCP2 pathway |
30 |
| Biomimetic nanoparticles for inflammation targeting |
29 |
| Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives |
29 |
| Recent developments in multimodality fluorescence imaging probes |
28 |
| SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade |
28 |
| Targeting the untargetable KRAS in cancer therapy |
28 |
| Recent advances of microneedles for biomedical applications: drug delivery and beyond |
26 |
| Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy |
26 |
| The application of CAR-T cell therapy in hematological malignancies: advantages and challenges |
25 |
| Development and application of hyaluronic acid in tumor targeting drug delivery |
22 |
| Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome |
22 |
| Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles |
22 |
| Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma |
21 |
| Efficient lung cancer-targeted drug delivery via a nanoparticle/MSC system |
20 |
| Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery |
19 |
| Hypocrellin A-based photodynamic action induces apoptosis in A549 cells through ROS-mediated mitochondrial signaling pathway |
17 |
| Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins |
17 |
| Aspirin alleviates endothelial gap junction dysfunction through inhibition of NLRP3 inflammasome activation in LPS-induced vascular injury |
17 |
| Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway |
17 |
| Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters |
17 |
| Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy |
16 |
| Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation |
16 |
| Advances in coamorphous drug delivery systems |
16 |
| Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy |
15 |
| Emerging transporter-targeted nanoparticulate drug delivery systems |
15 |
| Drug nanoclusters formed in confined nano-cages of CD-MOF: dramatic enhancement of solubility and bioavailability of azilsartan |
15 |
| Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression |
15 |
| Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A) |
15 |
| Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma |
14 |
| Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation |
14 |
| Small molecules for fat combustion: targeting obesity |
13 |
| Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting |
13 |
| Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications |
12 |
| Regulation of microbiota-GLP1 axis by sennoside A in diet-induced obese mice |
12 |
| Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation |
12 |
| Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect |
12 |
| Genome-wide characterization and analysis of bHLH transcription factors in Panax ginseng |
12 |
